出处
《中华高血压杂志》
CAS
CSCD
北大核心
2010年第9期820-822,共3页
Chinese Journal of Hypertension
基金
湖南省卫生厅(B2006-215)
湖南省博士后研究人员日常经费资助(2009年44号)
湖南省科技厅课题(2007FJ4135)
参考文献27
-
1Arita Y, Kihara S, Ouchi N, etal. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity[J]. Biochem Biophys Res Commun, 1999,257 (1): 79-83.
-
2Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose- specific gene, adiponectin[J]. Int J Obes Relat Metab Disord,2000,24(7):861-868.
-
3Tsao TS, Tomas E, Munrey HE, etal. Role of disulfide bonds in. Acrp30/Adiponectin structure and signaling specificity[J]. J Biol Chem,2003,278(50) : 101.
-
4Motoshima H, Wu X, Mahadev K, et al. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL[J]. Biochem Biophys Res Commun,2004,315(2) :26-71.
-
5Bora PS, Kaliappan S, Lyzogubov W, et al. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin[J]. Metabolism, 2007,581 (10) : 1977-1982.
-
6Furukawa S, Fujita T, Shimabukuro M, etal. Increased oxidative stress in obesity and its impact on metabolic syndrome[J]. J Clin Invest,2004,114(12) :1752-1761.
-
7Ouedraogo R, Xiangdong W, Shi-Qing X, et al. Adiponectin suppression of high-glucose induced reactive oxygen species in vascular endothelial cells[J]. Diabetes,2006,55(6) : 1840-1846.
-
8Goldstein BJ, Scalia R. Adipokines and vascular disease in diabetes[J]. Curr Diab Rep,2007,7(1):25-33.
-
9Zhu W, Cheng KK, Vanhoutte PM, etal. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention[J]. Clin Sci (Lond), 2008,114(5) : 361-374.
-
10Ouedraogo R, Gong Y, Berzins B, et al. Adiponectin deficiency increases leukocyte-endothetium interactions via upregulation of endothelial cell adhesion molecules in vivo[J]. J Clin Invest,2007, 117(6) : 1718-1726.
二级参考文献9
-
1Lewicki M, Kotyla P, Jankiewicz-Ziobro K, et al. [The role of adiponectin in atherosclerosis][J]. Pol Merkur Lekarski, 2006, 20(118):494-496.
-
2Lin SJ, Shyue SK, Hung YY, et al. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways[J]. Arterioscler Thromb Vasc Biol, 2005, 25(2):334-340.
-
3Verna L, Ganda C, Stemerman MB. In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression[J]. Arterioscler Thromb Vasc Biol, 2006, 26(6):1344-1349.
-
4Cullen JP, Morrow D, Jin Y, et al. Resveratrol, a polyphenolic phytostilbene, inhibits endothelial monocyte chemotactic protein-1 synthesis and secretion[J]. J Vasc Res, 2007, 44(1):75-84.
-
5Li CJ, Sun HW, Zhu FL, et al. Local adiponectin treatment reduces atherosclerotic plaque size in rabbits[J]. J Endocrinol, 2007,193(1):137-145.
-
6Chandrasekar B, Mummidi S, Mahimainathan L, et al. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin[J]. J Biol Chem, 2006, 281(22):15099-15109.
-
7Lee J, Jung E, Lee J, et al. Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1(AP-1) [J]. Life Sci, 2006, 79(26):2480-2485.
-
8Kato H, Kashiwagi H, Shiraga M, et al. Adiponectin acts as an endogenous antithrombotic factor[J]. Arterioscler Thromb Vasc Biol, 2006, 26(1):224-230.
-
9Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis[J]. J Biol Chem, 2002, 277(40):37487-37491.
共引文献3
-
1刘超.脂联素和2型糖尿病相关性的研究进展[J].医学临床研究,2012,29(6). 被引量:2
-
2谢春燕,李强翔.脂联素在肥胖、胰岛素抵抗中作用的研究进展[J].中国老年学杂志,2011,31(11):2141-2142. 被引量:8
-
3张竹林,张丽贞,马秀瑞,兰文燕.不同剂量瑞舒伐他汀对急性冠状动脉综合征患者血浆脂联素血管性血友病因子及内皮功能的影响[J].中国药物与临床,2014,14(7):937-939. 被引量:8
同被引文献39
-
1林灼锋.FGF21在动脉粥样硬化发病中的作用及其机制研究[D].广州:暨南大学,2011.
-
2高修仁.我国慢性稳定型心绞痛诊断与治疗指南解读[J].新医学,2007,38(11):704-707. 被引量:77
-
3Nguyen T, Lau DW. The obesity epidemic and its impact on hy- pertension[J]. Can J Cardiol, 2012,28( 3 ) : 326-333.
-
4Yvan-Charvet L, Quignard-Boulanga A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with ohesity[J]. Kidney Int,2011,79(2) :162-168.
-
5Lamacchia O, Nicastro V, Camarchio D, et al. Para and perirenal fat thickness is an independent predictor of chronic kidney dis- ease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients[J]. Nephrol Diatl Transplant, 2011,26 ( 3 ) : 892 -898.
-
6Ma LJ, Nakamura S, Aldigier JC, et al. Regression of glomeru- loselerosis with high-dose angiotensin inhibition is linked to de- creased plasminogen activator inhibitor-1[J]. J Am Soe Nephrol, 2005,16(4) :966-976.
-
7Tanaka R, Kon V, Yoshioka T, et al. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms[J]. Kidney Int, 1994,45(2):537 -553.
-
8Barandier C, Montani JP, Yang Z. Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity[J]. Am J Physiol Heart Circ Physiol. 2005,289(5) :H1807-H813.
-
9Boothby M, McGee KC, Tomlinson JW, et al. Adipocyte differ entialion, mitoehondrial gene expression and fat distribution:differences between zidovudine and tenofovir after 6 months[J]. Antivir Ther,2009,14(8) : 1089-1100.
-
10Wolf G, Chen S, Han DC, et al. Leptin and renal disease[J]. Am J Kidney Dis,2002,39(1) : 1-11.
引证文献2
-
1李昊,王亚萍,宋艳,张恒,李敏,索萌,高兰,田刚.高脂喂食诱导的肥胖大鼠肾周脂肪功能与肾损害的关系及替米沙坦干预的影响[J].中华高血压杂志,2015,23(11):1053-1061. 被引量:4
-
2陈海峰,吴峰,卢楠,郑炜平,林开阳.血清成纤维细胞生长因子21、脂联素与冠状动脉性心脏病的相关性[J].中华高血压杂志,2016,24(8):758-762. 被引量:15
二级引证文献19
-
1Su Gao,Xue Tian,Wei-Na Jiang,Yao Ma.Clinical efficacy and significance of serum fibroblast growth factor-21 and ghrelin in the treatment of type 2 diabetes complicated with coronary heart disease with integrated traditional Chinese and western medicine[J].Journal of Hainan Medical University,2018,24(22):13-17.
-
2刘蕾,殷艳蓉,宋艳,王亚萍,索萌,李敏,田刚.血管周围脂肪组织源瘦素促进高脂喂食诱导的肥胖大鼠血管平滑肌细胞增殖[J].中华高血压杂志,2017,25(3):272-279. 被引量:5
-
3郑梅凡,陈海峰.人成纤维细胞生长因子21与冠心病相关性的研究进展[J].福建医药杂志,2017,39(A01):65-68.
-
4李敏,刘蕾,宋艳,田刚,朱丹军.心外膜脂肪组织源瘦素促进高脂喂食诱导的肥胖大鼠心肌成纤维细胞增殖[J].中华高血压杂志,2018,26(3):233-240. 被引量:1
-
5谢勇,李东泽,李芳卉,逯光文,曹钰.成纤维细胞生长因子21抗动脉粥样硬化的研究进展[J].中国胸心血管外科临床杂志,2018,25(5):434-439. 被引量:3
-
6何雪环,黄光联,何英爱,浦荣,姚叶林.脂联素联合FGF-21、A-FABP在2型糖尿病的早期诊断中的应用价值分析[J].心电图杂志(电子版),2018,7(1):39-40. 被引量:2
-
7刘蕾,李敏,党夏薇,陈慧,宋艳,田刚,朱丹军.替米沙坦改善肥胖大鼠瘦素的促血管重构作用[J].中华高血压杂志,2018,26(6):526-534. 被引量:1
-
8高速,田雪,姜维娜,马尧.中西医结合治疗2型糖尿病合并冠心病的临床疗效及对血清成纤维细胞生长因子-21、Ghrelin的影响与意义[J].海南医学院学报,2018,24(22):1954-1958. 被引量:13
-
9杨文聪,尹建蓝,黄芳,陶宇佳,庄晓东,朱永宏.冠心病患者血清FGF21、PPARγ水平与冠状动脉狭窄程度的相关性[J].广东医学,2019,40(12):1817-1819. 被引量:6
-
10王娟,魏琼,朱宇,孟路路,慧露露,马学敏,翟岩峰.成纤维细胞生长因子21和脂联素水平对急性冠状动脉综合征患者近期预后的预测价值[J].解放军医药杂志,2020,32(9):44-48. 被引量:2
-
1闵艳,陈军宁.脂联素及基因多态性与糖尿病肾病[J].当代医学,2010,16(24):26-27. 被引量:1
-
2刘凤莲,何凤屏.脂联素水平及基因多态性与原发性高血压的研究进展[J].分子诊断与治疗杂志,2012,4(6):428-432. 被引量:1
-
3时照明,王长江,王佑民,章秋,周剑,胡红琳.人脂联素基因全长cDNA克隆[J].安徽医科大学学报,2004,39(2):116-118. 被引量:6
-
4叶瑶,于健.脂联素及基因多态性与非酒精性脂肪肝的研究进展[J].基础医学与临床,2014,34(9):1285-1288. 被引量:6
-
5王长江,王佑民,汝颖,章秋,胡红琳,陈明卫.脂联素基因H241P突变与老年人2型糖尿病[J].中华老年医学杂志,2005,24(5):348-350. 被引量:1
-
6李丙蓉,郑丹,邓华聪,刘金波,兰丽珍,郑宏庭.人脂联素重组腺病毒对内皮细胞增殖和一氧化氮合酶的影响[J].中华心血管病杂志,2006,34(12):1122-1125. 被引量:6
-
7高景顺,刘鹏.正五聚蛋白3检测在老年慢性心力衰竭中的诊疗价值[J].中国老年学杂志,2014,34(13):3741-3742. 被引量:5
-
8白怀,刘瑞.血管紧张素原研究进展[J].国外医学(临床生物化学与检验学分册),1999,20(6):246-248. 被引量:2
-
9冯琨,王丹,江红,杨玉芝.不同糖调节受损人群血浆Ghrelin水平及其相关因素分析[J].放射免疫学杂志,2009,22(4):411-412. 被引量:1
-
10李丙蓉,郑丹,邓华聪,兰丽珍,郑宏庭,刘金波.人脂联素基因的克隆及序列分析[J].重庆医科大学学报,2006,31(3):293-295. 被引量:1